跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,664 条关于
“DAVIO-2”
全部
64,664
临床试验
42,026
药物
7,314
机构
1,415
资讯
13,909
去年
EyePoint's EYP-1901 Shows Non-Inferiority to Aflibercept in Wet AMD
2年前
EYP-1901 Shows Promise in Reducing Treatment Burden for Wet AMD Patients in Phase 2 DAVIO-2 Trial
去年
EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUGANO Trial of Duravyu for Wet AMD
去年
EYP-1901 Shows Promise in Phase 3 LUGANO Trial for Wet AMD Treatment
去年
EyePoint Pharmaceuticals Doses First Patient in Phase 3 Trial of Duravyu for Wet AMD
2年前
Novel Therapies for Wet AMD Target Reduced Injection Burden and Broader VEGF Inhibition
去年
EYP-1901 Shows Promise in Wet AMD and DME Trials with Significant Reduction in Treatment Burden
9个月前
Two Novel Therapies Show Promise for Neovascular AMD: Duravyu Insert and Ixo-vec Gene Therapy Demonstrate Safety and Efficacy in Phase 2 Trials
去年
IMUNON's IMNN-001 Shows Promise in Advanced Ovarian Cancer Treatment
3个月前
Nickel(0)-Catalyzed Endo-Stereoselective [2+2] Cycloaddition Overcomes Norbornadiene Facial Bias
第 1 页,共 1391 页
上一页
下一页